Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing
CARE-VASH
2 other identifiers
interventional
7,908
1 country
1
Brief Summary
The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2030
Study Completion
Last participant's last visit for all outcomes
September 30, 2030
October 10, 2025
October 1, 2025
4 years
August 6, 2025
October 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Reach of MAT (Medications for Addiction Treatment)
* (percent of) Veterans who used Medications for Opioid Use Disorder (MOUD) for OUD, ≥1 prescription * (percent of) Veterans who used MOUD for OUD for 180 days since initial prescription (without a break ≥14 days in supply) * (percent of) Veterans who used Medications for Alcohol Use Disorder (MAUD) for AUD, ≥1 prescription * (percent of) Veterans who used MAUD for AUD for 180 days since initial prescription (without a break ≥14 days in supply)
18 months post-implementation
Reach of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)
* (percent of) Veterans with stimulant use disorder who had ≥1 visit for Cognitive Behavioral Therapy-Substance Use Disorders (CBT-SUD) or contingency management * (percent of) Veterans with substance use disorder with ≥1 CBT-SUD visit * (percent of) Veterans with substance use disorder with ≥9 CBT-SUD visits
18 months post-implementation
Adoption of MAT (Medications for Addiction Treatment)
% (percent of) Department of Housing and Urban Development - VA Supportive Housing (HUD-VASH) and mental health prescribers engaged with Veterans who ordered Medications for Opioid Use Disorder (MOUD) / Medications for Alcohol Use Disorder (MAUD) at least once
18 months post-implementation
Adoption of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)
% (percent of) Department of Housing and Urban Development - VA Supportive Housing (HUD-VASH) case managers who delivered ≥1 CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders) session
18 months post-implementation
Sustainment of MAT (Medications for Addiction Treatment)
* (percent of) Veterans who used Medications for Opioid Use Disorder (MOUD) for OUD, ≥1 prescription * (percent of) Veterans who used MOUD for OUD for 180 days since initial prescription (without a break ≥14 days in supply) * (percent of) Veterans who used Medications for Alcohol Use Disorder (MAUD) for AUD, ≥1 prescription * (percent of) Veterans who used MAUD for AUD for 180 days since initial prescription (without a break ≥14 days in supply) * (percent of) Department of Housing and Urban Development - VA Supportive Housing (HUD-VASH) and mental health prescribers engaged with Veterans who ordered Medications for Opioid Use Disorder (MOUD) / Medications for Alcohol Use Disorder (MAUD) at least once
18-27 months post-implementation
Sustainment of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)
* (percent of) Veterans with stimulant use disorder who had ≥1 visit for Cognitive Behavioral Therapy-Substance Use Disorders (CBT-SUD) or contingency management * (percent of) Veterans with substance use disorder with ≥1 CBT-SUD visit * (percent of) Veterans with substance use disorder with ≥9 CBT-SUD visits * (percent of) Department of Housing and Urban Development - VA Supportive Housing (HUD-VASH) case managers who delivered ≥1 CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders) session
18-27 months post-implementation
Secondary Outcomes (4)
Housing retention
1 year after implementation by cohort
Provider experience
Baseline and 18 months post-implementation
Cost impact of Medications for Addiction Treatment (MAT) and Cognitive Behavioral Therapy-Substance Use Disorders (CBT-SUD)
18 months (during the course of implementation)
Acute care utilization
1 year after implementation by cohort
Study Arms (3)
Replicating Effective Programs (REP)
EXPERIMENTALA stakeholder-informed training and technical assistance implementation strategy
REP + Consumer Engagement (CE)
ACTIVE COMPARATORREP plus CE package (educational materials, peer coaching, toolkit) to support MAT and CBT-SUD implementation.
Control Group
NO INTERVENTIONNo MAT or CBT-SUD implementation
Interventions
MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.
An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.
Eligibility Criteria
You may qualify if:
- Homeless-experienced Veterans (HEVs) enrolled in the Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073-1003, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sonya Emi Gabrielian, MD MPH
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
- PRINCIPAL INVESTIGATOR
Evelyn T Chang, MD MSHS
VA Greater Los Angeles Healthcare System, Sepulveda, CA
- PRINCIPAL INVESTIGATOR
Erin P Finley, PhD MPH
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
- PRINCIPAL INVESTIGATOR
Emily Treichler, PhD
VA San Diego Healthcare System, San Diego, CA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2025
First Posted
August 26, 2025
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
September 30, 2030
Study Completion (Estimated)
September 30, 2030
Last Updated
October 10, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL